Azelis Extends Agreement Further with Tagra Biotechnologies with an Exclusive Distribution Agreement in France and Benelux


Alternativ









Antwerp, Belgium - 24 January 2018
Azelis has been appointed as exclusive distributor by Tagra Biotechnologies to offer their range of Release on Demand™ (RND™) micro capsules in France and Benelux for all personal care applications. This new partnership builds on an existing partnership between the two companies in Canada, China, India, Australia, New Zealand and most of Europe.

Lito Ickowicz, Director Business Development, Tagra Biotechnologies states: "We are very happy with the extension. Azelis is a long-trusted partner of Tagra and we work well together, so the decision to further expand came only naturally to us. Together we aim to offer customers high quality technical service and innovative application insights."

Tony Craske, Market Segment Director, Azelis EMEA adds: "We are delighted to expand our partnership with Tagra once again. Azelis is well placed to increase market penetration in France and Benelux, and Tagra's patented technology for the encapsulation of actives, UV filters and pigments is a welcome addition to our portfolio to these markets. We both have a high focus on innovation and Tagra's market-leading ingredients will help our customers improve overall product performance."

Tagra Biotechnologies is the only company to patent the RND™ Microencapsulation Technology a method of providing stability, efficiency and controlled/immediate release for non-water soluble ingredients. Azelis' success relies on both the business and technical excellence of its people and the high quality ingredients delivered by principals. Given the strong technically-driven sales model of the team Azelis has confidence to grow the business further together with Tagra in France.

This technology enables the production of encapsulated ingredients including actives, vitamins, essential oils, flavonoids, silicones, pigments and sunscreens, all conforming to worldwide cosmetic regulations and suitable for a wide range of formulations. The agreement is effective immediately.


About Azelis
Azelis is a leading distributor of speciality chemicals and food ingredients present in over 40 countries across the globe with around 1,800 employees. Our knowledgeable teams of industry, market and technical experts are each dedicated to a specific market within Life Sciences and Industrial Chemicals. We offer a lateral value chain of complementary products to over 40,000 customers, creating a turnover of €1.8 billion. In the US we operate under a number of renowned co-brands that cater to the various markets in the region.

Throughout our extensive network of 39 application laboratories, our award-winning technical staff help customers develop formulations. We combine a global reach with a local focus to offer a reliable, integrated service to local customers and attractive business opportunities to principals. And we believe in building and nurturing solid, honest and transparent relationships with our people and partners.

For more information, please visit: www.azelis.com.


« back